尊龙凯时-人生就是搏[中国区]网站

A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects

Original Research Article：

Frontiers in Pharmacology

http:// 10.3389/fphar.2021.646171